企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：9年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：7948944
手机网站：http://wap.app17.com/c137908/
旗舰版网址：http://www.yajiml.com
技术文章
文献引用产品：HSCT6人骨髓间充质干细胞
点击次数：705 发布时间：2026/6/8 17:58:02
文章标题：Study on the Potential Molecular Mechanisms of Sodium Dehydroacetate (Na-DHA) Interfering With Bone Metabolism and Inducing Osteoporosis Based on Network Toxicology, Molecular Docking, and In Vitro Experimental Validation
作者列表：Weihong Qian, Qingqing Bao, Xiaoqing Tang, Wuchao Lu, Jiaxin Huang, Jiapeng Bao, Zhihong Yao
影响因子：3.8
期刊：Food Science & Nutrition
发表时间：2026-3-8
DOI:10.1002/fsn3.71633
文献主题：ABSTRACT
Sodium Dehydroacetate (Na-DHA), a widely used food additive, has raised concerns about the chronic health risks associated with long-term exposure. However, the potential impact of Na-DHA on bone ｍmbedbolism, its contribution to osteoporosis risk, and the specific molecular mechanisms remain unclear. This study aims to systematically elucidate the molecular mechanisms through which Na-DHA induces osteoporosis by integrating network toxicology, molecular docking, and in vitro experiments. Potential targets of Na-DHA were identified through multi-database screening. Osteoporosis-related genes were extracted from the GEO database (GSE156508) and subjected to differential and enrichment analyses. Common targets between Na-DHA and osteoporosis were identified using a Venn diagram. A protein–protein interaction (PPI) network was constructed using STRING, and core targets were selected through random forest analysis. Molecular docking of core targets with Na-DHA was perｆormed using AutoDock Vina. Human bone marrow mesenchymal stem cells (hBMSCs) were used as a model to assess cell viability using the CCK-8 assay, observe osteogenic/adipogenic differentiation phenotypes through Alizarin Red S and Oil Red O staining, and validate the expression of core targets and osteogenic genes by qRT-PCR and Western blot. Multi-database screening identified 325 potential Na-DHA targets and 500 osteoporosis-related differential genes. Of these, 34 common key targets were identified, which were mainly enriched in pathways related to lipid ｍmbedbolism, autophagy, and steroid biosynthesis. Random forest analysis identified LCMT1, ARHGEF11, and VCAM1 as core targets, and molecular docking revealed potential binding interactions between Na-DHA and all three targets. In vitro experiments demonstrated that 10 μM Na-DHA significantly inhibited hBMSCs viability, reduced calcium deposition in Alizarin Red S staining, increased lipid droplet accumulation in Oil Red O staining, and downregulated the expression of key osteogenic genes (BGLAP, SP7, RUNX2, ALPL). Moreover, Na-DHA significantly upregulated the mRNA and protein expression of LCMT1 and downregulated the mRNA and protein expression of ARHGEF11 and VCAM1. Na-DHA may increase osteoporosis risk by upregulating LCMT1, downregulating ARHGEF11 and VCAM1, and disrupting lipid ｍmbedbolism and the balance between osteogenesis and adipogenesis, ultimately disrupting bone ｍmbedbolic homeostasis. This study provides scientific evidence for assessing the skeletal health risks of Na-DHA and exploring potential intervention targets for bone toxicity.
原创作者：上海雅吉生物科技有限公司
